INFORMA MARKETS - INFRASTRUCTURE AND CONSTRUCTION
Demonstrations on the show floor offered first-hand learning of new techniques and applications to increase longevity and health of homes.
PROVIDENCE, RI / ACCESSWIRE / March 28, 2024 / JLC LIVE, New England's largest and most comprehensive residential construction event, took place last week, March 21-23, for three days of conference education and two days of exhibits at the Rhode Island Convention Center. The annual tradeshow hosted more than 260 exhibiting companies showcasing the latest innovations plus more than 40 classroom-style business education sessions, bringing the latest practices and technologies to the forefront of the industry.
To view this piece of content from www.accesswire.com, please give your consent at the top of this page.
JLC LIVE hosted its first-ever keynote address, sponsored by TimberHP, with renowned building science expert, Joe Lstirubek, Principal at the Building Science Corporation, focusing on advancing the building industry and adapting to changes in energy flows, equipment and materials. A full audience with standing room only, Lstirubek engaged hundreds of construction professionals providing unique insights and science-backed statistics from the past several decades, recognizing the evolving construction landscape. Additional conference education sessions featured jobsite management, construction skills and techniques, business operations and sales and design. The all-new Spanish education program offered classroom sessions on business administration, estimates, licenses and regulations, and technical clinics focused on framing and window installation best practices.
The most anticipated component of the event, live Building Clinics, covered a range of topics including drywall, high performance, air quality, deck building, window installation, stair building and building technology. Construction experts shared new product advancements to enhance traditional building methods, drawing large crowds of contractors, remodelers and home builders to learn directly from the expert builders throughout the engaging displays.
To view this piece of content from www.accesswire.com, please give your consent at the top of this page.
"The education sessions, keynote and show floor were all packed to the brim with construction professionals eager to connect with industry leaders to gain the tangible skills needed to build better and longer lasting homes," remarks Sue Pino, Show Director of JLC LIVE. "The enthusiasm and curiosity at this year's event was remarkable and is a strong testament to the hard-working residential construction professionals dedicated to perfecting their crafts, ultimately resulting in high-performing and more durable homes that we trust and live in."
Companies on the show floor also presented new techniques and processes through exhibitor-led demonstrations. Among the companies participating were Andersen Windows & Doors, showcasing window and door solutions, Simpson Strong-Tie presented safer and stronger decking and VERSATEX Building Products showed Xceed lap siding installation used for exterior building, displaying innovative and essential processes for contractors in the home improvement and remodeling sectors, estimated to reach $485 billion in spending in 2024.
For additional opportunities to connect with leading experts and companies, this year, the all-new residential construction event, Build Show LIVE arrives at the Austin Convention Center in Austin, Texas, November 7-9, 2024. Organized by Informa Markets in collaboration with The Build Show, founded by Matt Risinger of Risinger Build, Build Show LIVE will focus on high quality homebuilding and building science.
"Prepare for an unparalleled experience at Build Show LIVE, bringing experts from JLC LIVE and the Build Show together for a brand-new show in the South. Build Show LIVE will deliver cutting-edge education tailored for like-minded home builders, contractors, remodelers and architects alike. Join us for the groundbreaking event, meticulously crafted in collaboration with the industry's leading building science experts." - Matt Risinger, CEO, Risinger Build and Founder of The Build Show.
Registration for Build Show LIVE opens in June, visit www.buildshowlive.com for more information and to stay up to date on announcements.
About JLC LIVE
JLC LIVE is the most anticipated trade event of the year for residential construction. Remodelers, home builders, contractors, and other trade professionals learn from the leading industry experts through live on-floor building clinics, demonstrations and classroom-style conference sessions. Follow JLC LIVE on social at Facebook, Instagram, LinkedIn, Twitter and YouTube for the most up-to-date information.
About Informa Markets
Informa Markets, a subsidiary of Informa plc (LON:INF), creates platforms for industries and specialist markets to trade, innovate and grow. Our portfolio comprises more than 550 international B2B events and brands in markets including Engineering, Healthcare & Pharmaceuticals, Infrastructure, Construction & Real Estate, Fashion & Apparel, Hospitality, Food & Beverage, and Health & Nutrition, among others. We provide customers and partners around the globe with opportunities to engage, experience and do business through face-to-face exhibitions, specialist digital content and actionable data solutions. As the world's leading exhibitions organizer, we bring a diverse range of specialist markets to life, unlocking opportunities and helping them to thrive 365 days of the year. For more information, visit www.informamarkets.com.
Media Contact:
Abby Portwood
Informa Markets Infrastructure and Construction PR
ConstructionPR@informa.com
SOURCE: INFORMA MARKETS - INFRASTRUCTURE AND CONSTRUCTION
View the original press release on accesswire.com
To view this piece of content from www.accesswire.com, please give your consent at the top of this page.
About ACCESSWIRE
Subscribe to releases from ACCESSWIRE
Subscribe to all the latest releases from ACCESSWIRE by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from ACCESSWIRE
Young Girl Discovers a 3,500-year-old Egyptian Amulet9.12.2024 07:40:00 CET | Press release
During a family trip near an archaeological site in Hod Hasharon, 12-year-old Dafna Filshteiner found an ancient scarab. LONDON, UK / ACCESSWIRE / December 9, 2024 / Dafna Filshteiner, age 12, was recently hiking below the ancient site of Tel Qana in Hod Hasharon, when suddenly, to her surprise, she discovered an unusual find a beetle-like stone used as an Egyptian amulet about 3,500 years ago. "I was looking down at the ground to find porcupine needles and smooth pebbles," she says. "And suddenly I picked up an interesting stone. I showed it to my mother, and she said it was just an ordinary stone or a bead. But then I saw a decoration and stubbornly insisted it was more than that, so we searched on the Internet. There, we identified more photos of stones similar to what we had found. We realized that it was something special and immediately called the Antiquities Authority." The family turned to Mor Wiesel, an archaeologist at the Israel Antiquities Authority, who thanked Dafna and h
Loar Announces Launch of Public Offering9.12.2024 06:30:00 CET | Press release
WHITE PLAINS, NY / ACCESSWIRE / December 9, 2024 / Loar Holdings Inc. (NYSE:LOAR) ("Loar") announced today that it has launched the roadshow for the public offering of 4,750,000 shares of its common stock, including 1,583,333 shares offered by certain stockholders and 3,166,667 shares offered by Loar. In addition, such selling stockholders expect to grant the underwriters a 30-day option to purchase up to 712,500 additional shares of common stock at the public offering price, less underwriting discounts and commissions. Loar intends to use the net proceeds from this offering for repayment of borrowings outstanding under its credit agreement and, to the extent of any remaining proceeds, for general corporate purposes, including working capital. Loar will not receive any of the proceeds from the sale of common stock offered by the selling stockholders, including any common stock sold pursuant to any exercise by the underwriters of their option to purchase additional shares. Jefferies and
BioNxt Solutions Reports Progress on BNT23001 Development for Multiple Sclerosis Treatment9.12.2024 03:05:00 CET | Press release
VANCOUVER, BC / ACCESSWIRE / December 9, 2024 / BioNxt Solutions Inc. ("BioNxt" or the "Company") (CSE:BNXT)(OTC PINK:BNXTF)(FSE:BXT), a bioscience company specializing in advanced drug delivery systems, has achieved key milestones in the development of BNT23001, its proprietary sublingual thin-film (OFD) formulation of Cladribine for the treatment of Multiple Sclerosis (MS). These achievements in 2024 lay the groundwork for clinical trials and regulatory submissions in 2025, reinforcing BioNxt's commitment to advancing patient-centric therapeutic solutions. 2024 Milestones: Establishing a Strong Foundation for Cladribine Thin-Film Development Preclinical Success: BNT23001 demonstrated high absorption rates of Cladribine through sublingual delivery in pharmacokinetic (PK) studies conducted in animal models. These studies confirmed the product's bioequivalence to the originator therapy, Mavenclad®, and validated the thin-film's rapid absorption and safety profile. Toxicity studies furth
ProteinQure to Present Data on PQ203, a Novel Peptide-Drug Conjugate for Triple Negative Breast Cancer, at 2024 San Antonio Breast Cancer Symposium6.12.2024 12:30:00 CET | Press release
TORONTO, ON / ACCESSWIRE / December 6, 2024 / ProteinQure, the leading company in computational design of peptide therapeutics, will be presenting compelling new data on the progress of their lead triple negative breast cancer (TNBC) drug PQ203 (December 12, 2024 presentation ID: P4-12-17) at the 2024 San Antonio Breast Cancer Symposium. PQ203 is a novel Peptide Drug Conjugate composed of a Sortilin receptor targeting peptide conjugated to the cytotoxic agent monomethyl auristatin E. The Sortiin receptor is expressed in a high percentage of diseased tissue from TNBC patients and as such represents an innovative treatment for this challenging sub-type of breast cancer. ProteinQure has recently generated data that PQ203 exhibits potent efficacy in a patient-derived xenograft (PDX) model resistant to Sacituzumab Govitecan (Trodelvy™), an antibody drug conjugate that is the emerging standard of care for metastatic TNBC. Additionally, PQ203 has shown an encouraging safety profile. Based on
Accurate Background Partnering with Konfir to Provide Fast, Secure Instant Employment Verification in the United Kingdom5.12.2024 09:15:00 CET | Press release
IRVINE, CA / ACCESSWIRE / December 5, 2024 / Accurate Background, headquartered in Irvine, CA, and the largest privately held and minority-owned global provider of compliant background checks, drug and health screening, and workforce monitoring solutions, has announced a new partnership with Konfir, an innovative company providing employment verification technology in the UK. This collaboration will provide Accurate's clients access to Konfir's real-time verification tools via Accurate technology. Accurate's integration of Konfir's instant employment verification API will allow candidates to aggregate real-time data from multiple data sources including Payroll, HMRC, and Open Banking, streamlining screening processes and reducing time-to-hire. In addition, Accurate will now offer enhanced fraud mitigation tools through Konfir's suite of insights helping employers identify potential hiring risks more effectively. Kevin Stone, Sales & Marketing Director at Accurate, commented: "At Accura
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom